Back to top
more

GW Pharmaceuticals PLC (GWPH)

(Delayed Data from NSDQ)

$175.50 USD

175.50
434,163

+2.34 (1.35%)

Updated May 3, 2019 04:00 PM ET

After-Market: $175.65 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[GWPH]

Reports for Purchase

Showing records 1 - 20 ( 65 total )

Industry: Medical - Products

Record: 1

02/04/2021

Company Report

Pages: 3

Downgrade to Neutral on Acquisition by Jazz Pharmaceuticals; Target to $220

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 2

02/03/2021

Daily Note

Pages: 2

MORNING OUTLOOK

Provider: M Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 3

01/27/2021

Industry Report

Pages: 15

2021 Roadmap of Key Events Across Our Coverage

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 4

01/12/2021

Daily Note

Pages: 3

GW Pharma: 4Q Results Beat Street Expectations and 2021 Priorities Shared; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 5

12/21/2020

Industry Report

Pages: 10

The Bugs for Your Gut: Takeaways from the Recent Autism Spectrum Disorders Symposium

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 6

11/04/2020

Company Report

Pages: 5

3Q Earnings Beat Restores Some Epidiolex Momentum; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 7

11/03/2020

Daily Note

Pages: 2

MORNING OUTLOOK

Provider: M Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 8

08/07/2020

Company Report

Pages: 5

Flat Sales in 2Q20 but Poised for Growth; Reiterate Buy, Nudge PT Down to $162

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 9

08/04/2020

Company Report

Pages: 4

Epidiolex Receives Label Expansion for Seizures Associated With TSC; Reiterate Buy, Nudge PT up to $164

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 10

07/08/2020

Daily Note

Pages: 5

Nabiximols Offers Meaningful Opportunity for GW?s US Platform; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 11

05/12/2020

Company Report

Pages: 5

Epidiolex Shows More Than Just Resilience; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 12

02/27/2020

Company Report

Pages: 5

The Cost of Growth; Tweak Target to $161; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 13

02/26/2020

Daily Note

Pages: 2

MORNING OUTLOOK

Provider: M Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 14

02/12/2020

Industry Report

Pages: 13

2020 Roadmap of Key Events Across Our Coverage

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 15

02/07/2020

Company Report

Pages: 4

Updating Estimates

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 16

12/18/2019

Company Report

Pages: 4

AES Confirms Growth Profile; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 17

11/08/2019

Company Report

Pages: 5

The Launch Still Looks Good to Us; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 18

10/30/2019

Company Report

Pages: 29

Pipeline in a Plant; Initiate at Buy With $170 Price Target

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 19

04/30/2019

Industry Report

Pages: 19

Cannabis - Where are we and where are we going?

Provider: Edison Investment Research Limited

Analyst: JACOBS M

Price: .00

Research Provided by a Third Party

Industry: Medical - Products

Record: 20

08/08/2018

Company Report

Pages: 2

Continuing to Blaze the Trail in Cannabinoid-Derived Pharmaceuticals

Provider: Beacon Securities Ltd.

Analyst: KIDECKEL D

Price: 10.00

Research Provided by a Third Party
// eof